Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Lymphoid Leukemia" returned 9 results:

A single-arm, open-label Phase IIa study to evaluate the efficacy and safety of copanlisib monotherapy in patients with relapsed or refractory mantle cell lymphoma (MCL), who failed ibrutinib treatment or were unable to tolerate ibrutinibe
Principal Investigator(s): Dr. Joshua Brody

A Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of the Combination of Ibrutinib with Nivolumab in Subjects with Hematologic Malignancies
Principal Investigator(s): Dr. joshua Brody

A multicenter safety study of unlicensed, investigational cryopreserved cord blood units (CBUs) manufactured by the National Cord Blood Program (NCBP) and provided for unrelated hematopoietic stem cell transplantation of pediatric and adult patients
Principal Investigator(s): Luis M. Isola

A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 inCombination with Obinutuzumab, and ACP-196 Monotherapy inSubjects with Previously Untreated Chronic Lymphocytic Leukemia
Principal Investigator(s): Dr. Joshua Brody

A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications
Principal Investigator(s): Luis M. Isola

A Phase II Controlled Trial of a Single ProHema-CB unit (Ex Vivo CXCR4-Upregulated CD34+ Hematopoietic Progenitor Cells, Cord Blood) As Part of a Double Umbilical Cord Blood Transplant Following Myeloablative Conditioning For Patients Age 15-55 Years With Hematologic Malignancies
Principal Investigator(s): Luis M. Isola

An Inter group Phase II Clinical Trial for Adolescents and Young Adults with Untreated Acute Lymphoblastic Leukemia
Principal Investigator(s): Celia L. Grosskreutz

BMT CTN 1101: A multi-center, phase 3, randomized trial of reduced intensity conditioning and transplantation of double unrelated umbilical cord blood versus HLA-Haploidentical related bone marrow for patients with hematological malignancies
Principal Investigator(s): Adriana Malone

Filgrastim-Mobilized Blood Stem Cells for Transplantation
Principal Investigator(s): Luis M. Isola